Senior insider sale
Chief Executive Officer at UNITY BIOTECHNOLOGY, INC. — senior position signals high conviction
$24.1K
7.35K shares
What this filing means
GHOSH ANIRVAN plans to sell 7.35K shares of UNITY BIOTECHNOLOGY, INC. valued at approximately $24.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/3/2023ACC: 0000950170-23-016982
DirectorOfficer· Chief Executive Officer
Since Mar 2020
7.35K
Shares to sell
$24.1K
Approx. market value
588.00
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units granted in 2022 under the Issuer's 2018 Incentive Award Plan
N/A
5/1/2023
588.00Total acquired588.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2023 | Restricted Stock Units granted in 2022 under the Issuer's 2018 Incentive Award Plan N/A | 588.00 | — |
| Total | 588.00 | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.02K
Market value
$2.2K
5/1/2023
—Completed
Units to sell
1.96K
Market value
$3.3K
3/31/2023
—Completed
Units to sell
1.21K
Market value
$4.8K
3/14/2023
—Completed
Units to sell
2.57K
Market value
$12.5K
2/2/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
588.00
Market value
$1.3K
5/2/2023
Total
Units
7.35K
Value
$24.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2023 | 1.02K | $2.2K | — | Completed |
3/31/2023 | 1.96K | $3.3K | — | Completed |
3/14/2023 | 1.21K | $4.8K | — | Completed |
2/2/2023 | 2.57K | $12.5K | — | Completed |
| Planned — Approximate Date | ||||
5/2/2023 | 588.00 | $1.3K | NASDAQ | Planned |
| Total | 7.35K | $24.1K | ||